The International Journal of Frontier Sciences

(ISSN: 2618-0367) Open Access Journal
Rss Feed:
image missing

Table of Contents

Int J Front Sci, Volume 8, Issue 1 (January 2026)
select all articles
Export citation of selected articles as:
Int J Front Sci 2026, 8(1), 6; doi: 10.37978/tijfs.v08i01.006
Received: 5 Jun 2026 / Accepted: 27 Aug 2026 / Published: 23 Oct 2026
Background: Punjab, Pakistan’s most populous province, faces burdens of communicable and non-communicable diseases (NCDs), rapid population growth, and inequitable healthcare access. Despite healthcare investments, challenges remain in achieving Universal Health Coverage (UHC) and Sustainable Development Goals (SDGs), highlighting the need for comprehensive health
[...] Read more.
Background: Punjab, Pakistan’s most populous province, faces burdens of communicable and non-communicable diseases (NCDs), rapid population growth, and inequitable healthcare access. Despite healthcare investments, challenges remain in achieving Universal Health Coverage (UHC) and Sustainable Development Goals (SDGs), highlighting the need for comprehensive health and population sector assessment. The objective of this study was to assess the current status of health and population services in Punjab, Pakistan, identify key system gaps using the World Health Organization (WHO) Health System Building Blocks Framework, and propose evidence-based recommendations for health system strengthening. Methods: A narrative review and policy analysis were conducted using a PRISMA-informed search of PubMed, Scopus, Web of Science, and Google Scholar, and reports from WHO, UNICEF, UNFPA, the World Bank, and the Government of Punjab. Publications (2020–2025) were screened, with 87 eligible studies included. The findings were synthesized using the WHO Health System Building Blocks Framework to identify key gaps and policy priorities. Results: The review found improvements in healthcare infrastructure, maternal and child health, immunization, and digital health. However, persistent gaps include inequitable access, workforce shortages, fragmented information systems, limited access to essential medicines, inadequate primary healthcare (PHC) investment, and weak governance. High maternal and child mortality, childhood stunting, rising NCDs, unmet family planning needs, and rapid population growth continue to strain Punjab’s health system. Conclusions: Despite notable progress, persistent health system gaps continue to impede UHC and SDG achievement in Punjab. Strengthening PHC, governance, workforce capacity, and preventive services is essential for sustainable health outcomes. Full article
Int J Front Sci 2026, 8(1), 5; doi: 10.37978/tijfs.v08i01.005
Received: 12 Jul 2026 / Accepted: 27 Aug 2026 / Published: 15 Oct 2026
Background: Clinician-facing artificial intelligence-based clinical decision support systems (AI-CDSSs) are increasingly evaluated with real-world data, but evidence on implementation, human factors, responsible AI, and patient benefit remains unclear. The objective of this research is to map applications, technical characteristics, evaluation approaches, integration, outcomes,
[...] Read more.
Background: Clinician-facing artificial intelligence-based clinical decision support systems (AI-CDSSs) are increasingly evaluated with real-world data, but evidence on implementation, human factors, responsible AI, and patient benefit remains unclear. The objective of this research is to map applications, technical characteristics, evaluation approaches, integration, outcomes, and implementation gaps of clinician-facing AI-CDSSs in real-world health care settings. Methods: PubMed/MEDLINE was searched on 15 June 2026 using the same strategy for each publication year from 2020 to 2026, changing only the date range. After duplicate removal and rule-based prescreening, available PMC XML and outside-PMC reports were evaluated against clinical, patient-oriented, practical, and translational criteria. AI-assisted screening and charting received targeted human review and TA200/FT150/DX120 quality control; full-corpus dual-human screening was not performed. Results: Of 14,097 canonical annual records, 14,083 unique records were screened; 5140 reports were sought and 3767 were considered for eligibility. The review included 1181 reports, mapping to 1180 candidate report families in the minimal duplicate-report check. Final stages were clinical validation, 741 (62.7%); prospective/user evaluation, 270 (22.9%); and implementation/impact evaluation, 170 (14.4%). Separate internal, external, multicenter and temporal validation extraction signals were detected in 707 (59.9%), 441 (37.3%), 312 (26.4%) and 27 (2.3%) reports, respectively. Safety, fairness/equity, explainability/interpretability and economic/resource evaluation signals were detected in 98 (8.3%), 61 (5.2%), 155 (13.1%) and 182 (15.4%) reports, respectively. Conclusions: Evidence remains dominated by validation rather than prospective, implementation, and impact studies. More comprehensive evaluation and reporting of temporal validation, technical integration, safety, fairness, explainability, economics, and post-deployment governance across settings, populations, devices, and clinical workflows are needed to demonstrate accountable clinical value beyond technical functionality. Full article
Int J Front Sci 2026, 8(1), 4; doi: 10.37978/tijfs.v08i01.004
Received: 6 Feb 2026 / Accepted: 10 Aug 2026 / Published: 25 Aug 2026
Background: Deepfake technology is a major social concern due to the rapid development of Artificial Intelligence (AI), especially in machine learning (ML) and deep learning (DL). Deepfakes are artificially modified videos and images that effectively change a person’s facial features or expressions to
[...] Read more.
Background: Deepfake technology is a major social concern due to the rapid development of Artificial Intelligence (AI), especially in machine learning (ML) and deep learning (DL). Deepfakes are artificially modified videos and images that effectively change a person’s facial features or expressions to misrepresent reality. These videos and images, often unnoticed by casual observers, present significant ethical, political, and social implications, as they can spread misinformation, damage reputations, and influence public perception. This study is an attempt to detect artificially modified videos by analyzing each frame using DL. We use ResNet-50 architecture, a well-known Convolutional Neural Network (CNN) model, to identify tampered videos. Methods: The system is trained using the Celebrity Deep Fake dataset, which includes numerous original and fake video samples. The model assesses whether each frame is original or tampered with after the videos have been split into frames. The system is tested and evaluated using standard metrics, including accuracy, precision, recall, and F1-score. Results: The model achieved 82.33% accuracy, 76.70% precision, 89.15% recall, and an F1-score of 82.46%. These results indicate that deepfake videos were correctly detected and that the model was efficient at identifying most real deepfake instances. In addition, the F1-score of 82.46% is further evidence of the model’s stability, as it ensures both high accuracy and coherence across numerous cases. Conclusions: The findings indicate that the proposed model works effectively compared to existing deepfake methods. In the future, we intend to use a richer dataset with more resources, which may further enhance the accuracy of the model. Full article
Int J Front Sci 2026, 8(1), 3; doi: 10.37978/tijfs.v08i01.003
Received: 31 Jan 2026 / Accepted: 29 Jun 2026 / Published: 3 Jul 2026
Background: Infective endocarditis (IE) is a life-threatening condition associated with high morbidity and mortality, particularly when complicated by neurological events. Ischemic stroke occurs in up to 30% of IE cases and poses a major challenge regarding the timing of cardiac surgery due to
[...] Read more.
Background: Infective endocarditis (IE) is a life-threatening condition associated with high morbidity and mortality, particularly when complicated by neurological events. Ischemic stroke occurs in up to 30% of IE cases and poses a major challenge regarding the timing of cardiac surgery due to the risk of hemorrhagic transformation. Case Presentation: We present the case of a 31-year-old Caucasian non-working female featuring progressive dyspnea, orthopnea, palpitations and retrosternal chest discomfort for the last two months. She had no cardiovascular or chronic medical disease before admission. One month prior, she developed sudden right-sided hemiparesis. Neuroimaging showed ischemic stroke with hemorrhagic transformation. Blood cultures grew Streptococcus viridans and transthoracic echocardiography showed a large, mobile vegetation (app. 13 mm) on the mitral valve. Due to high embolic risk, surgical treatment was undertaken following multidisciplinary decision with consideration by cardiology, neurology, neurosurgery, and cardiac surgery teams. After stabilization the patient required urgent mitral valve replacement with a mechanical prosthesis. Postoperatively, the patient was neurologically and hemodynamically intact, with no progression of hemorrhagic transformation. She received a 6-week course of targeted intravenous antibiotic therapy. At 3-month follow-up, she noted marked neurological recovery with motor strength up to approximately 4 out of 5 with independent ambulation and no cardiac complications. Conclusions: This case study suggests that early surgical management is safely available for several patients with ischemic and hemorrhagic transformation complications of IE only when considering carefully tailored patient multidisciplinary evaluation and close perioperative monitoring. Full article
Int J Front Sci 2026, 8(1), 2; doi: 10.37978/tijfs.v08i01.002
Received: 13 Feb 2026 / Accepted: 11 Jun 2026 / Published: 1 Jul 2026
Background: Digital transformation has become essential for strengthening health systems in low- and middle-income countries (LMICs), which often experience workforce shortages, fragmented governance, inadequate infrastructure, and ongoing health inequities. Advances in artificial intelligence (AI), big data analytics, interoperability frameworks, precision medicine (PM), and
[...] Read more.
Background: Digital transformation has become essential for strengthening health systems in low- and middle-income countries (LMICs), which often experience workforce shortages, fragmented governance, inadequate infrastructure, and ongoing health inequities. Advances in artificial intelligence (AI), big data analytics, interoperability frameworks, precision medicine (PM), and connected health technologies present opportunities to improve access, quality, efficiency, and resilience within these systems. However, the implementation of these technologies remains inconsistent due to structural, regulatory, financial, and capacity-related barriers. This narrative review synthesizes current evidence on digital health transformation in LMICs, focusing on emerging technologies, system-level challenges, and future directions. Methods: A narrative literature review of peer-reviewed articles and grey literature published between 2015 and 2025 was conducted to examine digital health initiatives across health system functions. Results: LMICs have significant opportunities to utilize digital health to drive transformative reforms in their health systems. However, they face challenges stemming from a persistent “triple divide” that includes gaps in infrastructure, limitations in digital literacy, and disparities in data access. Additional barriers to progress include fragmented, non-interoperable systems; weak regulatory frameworks; deficiencies in data governance; infrastructure limitations; workforce shortages; algorithmic bias; and unequal access to resources. Promising solutions highlight the importance of developing interoperable digital public infrastructure (DPI), utilizing AI-enabled data harmonization, implementing federated learning, adapting governance models, and designing people-centered systems. Conclusions: Digital health has the potential to significantly enhance the resilience, equity, and sustainability of health systems in LMICs. This transformation can be achieved through coordinated national strategies, strong governance, inclusive and interoperable digital architectures, and consistent investment in workforce and institutional capacity. Future initiatives should prioritize ethical, context-sensitive AI, interoperability, and locally driven innovation to ensure lasting improvements in population health. Full article
Int J Front Sci 2026, 8(1), 1; doi: 10.37978/tijfs.v08i01.001
Received: 1 Feb 2026 / Accepted: 11 Apr 2026 / Published: 14 May 2026
Nipah virus (NiV) is a highly pathogenic zoonotic henipavirus that causes severe respiratory and neurological disease with case-fatality rates of 40–75%. Despite its epidemic potential, no licensed vaccines or specific antiviral therapies are currently available. Consequently, the World Health Organization (WHO) has prioritized
[...] Read more.
Nipah virus (NiV) is a highly pathogenic zoonotic henipavirus that causes severe respiratory and neurological disease with case-fatality rates of 40–75%. Despite its epidemic potential, no licensed vaccines or specific antiviral therapies are currently available. Consequently, the World Health Organization (WHO) has prioritized NiV and established a research and development roadmap to accelerate the development of diagnostics, therapeutics, and vaccines. Since its emergence during outbreaks in Malaysia and Singapore in 1998–1999, NiV has caused recurrent outbreaks in South and Southeast Asia, including multiple events in West Bengal, India, with the most recent cases reported in January 2026. NiV transmission occurs through direct contact with infected animals, consumption of contaminated food products, or human-to-human transmission, with fruit bats (Pteropus spp.) serving as natural reservoirs. Clinical manifestations range from mild illness to severe acute respiratory disease and fatal encephalitis, with rapid neurological deterioration. Laboratory diagnosis relies primarily on molecular detection by RT–PCR and serological assays, such as ELISA. However, diagnostic development is limited by the scarcity of well-characterized clinical specimens, gaps in external quality assessment, and insufficient surveillance data. This article reviews current laboratory diagnostic strategies and outlines WHO research priorities for 2024–2029, emphasizing rapid point-of-care diagnostics, strengthened laboratory capacity, particularly in low- and middle-income countries, and integration within One Health surveillance frameworks to improve outbreak preparedness and response. Full article